SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-000056
Filing Date
2024-01-04
Accepted
2024-01-04 09:00:25
Documents
14
Period of Report
2024-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_010424.htm   iXBRL 8-K 27631
2 EXHIBIT 4.1 exh_41.htm EX-4.1 68687
3 EXHIBIT 99.1 exh_991.htm EX-99.1 4398
  Complete submission text file 0001171843-24-000056.txt   290734

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xbit-20240103.xsd EX-101.SCH 3015
5 XBRL LABEL FILE xbit-20240103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE xbit-20240103_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT f8k_010424_htm.xml XML 3071
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 24509878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)